Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-21 · accession 0001127602-23-016428 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-21 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | -9,302 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-21 | M | A | 9,302 | $0.00 | 40,332 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2023-05-21 | M | D | 9,302 | $0.00 | 0 | D | $0.00 · — to — | 9,302 Common Stock | (F1) Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. (F2) Each restricted stock unit represents a contingent right to receive one share of common stock. |